InsidersTradesSigma
Follow the BioNTech SE share price and the full insider trade history of the company, a listed equity based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €19.7bn. The latest transaction was filed on 23 April 2026 (Cession). Among the most active insiders: Poetting Sierk. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
BioNTech SE is a German biopharmaceutical company focused on developing immunotherapies and vaccines. It is best known for its COVID-19 vaccine developed in collaboration with Pfizer.